Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Journal articles
, 2009, 'HMG CoA reductase inhibitors (statins) for dialysis patients', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD004289.pub4
, 2009, 'HMG CoA reductase inhibitors (statins) for kidney transplant recipients', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD005019.pub3
, 2009, 'HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD007784
, 2009, 'Lowering blood pressure reduces renal events in type 2 diabetes', Journal of the American Society of Nephrology, 20, pp. 883 - 892, http://dx.doi.org/10.1681/ASN.2008070667
, 2009, 'Renal and cardio-protective effects of direct renin inhibition: A systematic literature review', Journal of Hypertension, 27, pp. 2321 - 2331, http://dx.doi.org/10.1097/HJH.0b013e3283310f92
, 2008, 'Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials', European Heart Journal, 29, pp. 2669 - 2680, http://dx.doi.org/10.1093/eurheartj/ehn427
, 2008, 'The relationship between proteinuria and coronary risk: A systematic review and meta-analysis', Plos Medicine, 5, pp. 1486 - 1495, http://dx.doi.org/10.1371/journal.pmed.0050207
, 2008, 'TWENTY YEAR CANCER OUTCOMES OF A RANDOMISED TRIAL OF IMMUNOSUPPRESSION IN KIDNEY TRANSPLANT RECIPIENTS: RESULTS OF THE AUSTRALIAN MULTICENTRE TRIAL OF CYCLOSPORINE WITHDRAWAL', Transplantation, 86, pp. 102 - 102, http://dx.doi.org/10.1097/01.tp.0000332497.13679.a7
, 2008, 'Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand', American Journal of Public Health, 98, pp. 1306 - 1313, http://dx.doi.org/10.2105/AJPH.2007.116020
, 2008, 'Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger people: Meta-analysis of randomised trials', BMJ, 336, pp. 1121 - 1123, http://dx.doi.org/10.1136/bmj.39548.738368.BE
, 2008, 'Effects of statins in patients with chronic kidney disease: Meta-analysis and meta-regression of randomised controlled trials', BMJ, 336, pp. 645 - 651, http://dx.doi.org/10.1136/bmj.39472.580984.AE
, 2008, 'High prevalence of chronic kidney disease in Thailand', Kidney International, 73, pp. 473 - 479, http://dx.doi.org/10.1038/sj.ki.5002701
, 2008, 'Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial', Kidney International, 73, pp. 963 - 970, http://dx.doi.org/10.1038/ki.2008.5
, 2007, 'The burden of blood pressure-related disease: A neglected priority for global health', Hypertension, 50, pp. 991 - 997, http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.095497
, 2007, 'New insights from ADVANCE.', Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 25 Suppl 1
, 2007, 'Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system', Journal of Hypertension, 25, pp. 951 - 958, http://dx.doi.org/10.1097/HJH.0b013e3280bad9b4
, 2007, 'Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial', Health and Quality of Life Outcomes, 5, pp. 21, http://dx.doi.org/10.1186/1477-7525-5-21
, 2007, 'Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: Data from the PROGRESS study', Journal of the American Society of Nephrology, 18, pp. 2766 - 2772, http://dx.doi.org/10.1681/ASN.2007020256
, 2007, 'Outcomes of Aortic Stenosis—A Comparison of Dialysis Patients Versus Controls', Heart, Lung and Circulation, 16, pp. S79 - S79, http://dx.doi.org/10.1016/j.hlc.2007.06.203
, 2006, 'Diuretics: A modern day treatment option? (Review article)', Nephrology, 11, pp. 419 - 427, http://dx.doi.org/10.1111/j.1440-1797.2006.00598.x
, 2006, 'ADVANCE: Breaking new ground in type 2 diabetes', Journal of Hypertension, 24, pp. S22 - S28, http://dx.doi.org/10.1097/01.hjh.0000240043.50838.28
, 2006, 'ADVANCE : breaking new ground in type 2 diabetes', Journal of Hypertension (Supplement), 24, pp. S22 - S28
, 2006, 'ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes.', Blood Pressure, 15, pp. 340 - 346
, 2005, 'The CARI guidelines. Dialysis adequacy (HD) guidelines.', Nephrology Carlton Vic, 10 Suppl 4, pp. S61 - S80
, 2005, 'Hematuria in thin basement membrane nephropathy', Seminars in Nephrology, 25, pp. 146 - 148, http://dx.doi.org/10.1016/j.semnephrol.2005.01.005
, 2005, 'Blood urea sampling methods', Nephrology, 10, http://dx.doi.org/10.1111/j.1440-1797.2005.00464_2.x
, 2005, 'Dialysis membranes', Nephrology, 10, http://dx.doi.org/10.1111/j.1440-1797.2005.00464_3.x
, 2005, 'Duration and frequency of haemodialysis therapy', Nephrology, 10, http://dx.doi.org/10.1111/j.1440-1797.2005.00464_4.x
, 2005, 'Haemodialysis anticoagulation and adequacy', Nephrology, 10, http://dx.doi.org/10.1111/j.1440-1797.2005.00464_6.x
, 2005, 'Water quality for haemodialysis', Nephrology, 10, http://dx.doi.org/10.1111/j.1440-1797.2005.00464_5.x
, 2003, 'Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells', Kidney and Blood Pressure Research, 26, pp. 27 - 33, http://dx.doi.org/10.1159/000069761
, 2003, 'Accelerated progression of calcific aortic stenosis in dialysis patients.', Nephron Clinical Practice, 94, pp. c40 - c45, http://dx.doi.org/10.1159/000071280
, 2002, 'Factors affecting outcome after percutaneous renal artery stent insertion', Journal of Nephrology, 15, pp. 649 - 654
, 2002, 'ACCELERATED PROGRESSION OF CALCIFIC AORTIC STENOSIS IN DIALYSIS PATIENTS', Nephrology, 7, pp. A106 - A106, http://dx.doi.org/10.1046/j.1440-1797.2002.00007-1-106.x
, 2002, 'LONG TERM OUTCOMES OF STENT INSERTION FOR RENAL ARTERY STENOSIS', Nephrology, 7, http://dx.doi.org/10.1046/j.1440-1797.2002.00007-1-7.x
, 2002, 'LOVASTATIN DOWNREGULATES RENAL MYOFIBROBLAST FUNCTION IN VITRO', Nephrology, 7, http://dx.doi.org/10.1046/j.1440-1797.2002.00007-1-2.x
, 2002, 'PARATHYROID HORMONE HAS A PROSCLEROTIC EFFECT ON VASCULAR SMOOTH MUSCLE CELLS', Nephrology, 7, http://dx.doi.org/10.1046/j.1440-1797.2002.00007-1-69.x
, 2001, 'Pharmacological intervention in renal fibrosis and vascular sclerosis', Journal of Nephrology, 14, pp. 332 - 339
, 2001, 'Treatment of renovascular disease with percutaneous stent insertion: Long-term outcomes', Australasian Radiology, 45, pp. 438 - 443, http://dx.doi.org/10.1046/j.1440-1673.2001.00953.x
, 1999, 'Haemolytic uraemic syndrome and prostatic cancer', Australian and New Zealand Journal of Medicine, 29, pp. 383 - 384, http://dx.doi.org/10.1111/j.1445-5994.1999.tb00730.x
Conference Papers
, 2026, 'Impact of Semaglutide on Kidney, Cardiovascular, and Mortality Outcomes by Baseline BMI and Weight Loss in People with T2D and CKD—Data from the FLOW Trial', in Diabetologie und Stoffwechsel, Georg Thieme Verlag KG, presented at Revolution der Mittel – Realität der Menschen, 13 May 2026 - 16 May 2026, http://dx.doi.org/10.1055/s-0046-1820050
, 2026, 'Semaglutide Reduced Risks of Major Kidney Outcomes Irrespective of CKD Severity in the FLOW Trial', in Diabetologie und Stoffwechsel, Georg Thieme Verlag KG, presented at Revolution der Mittel – Realität der Menschen, 13 May 2026 - 16 May 2026, http://dx.doi.org/10.1055/s-0046-1820049
, 2025, 'Biomarker Insights from the Phase 3 APPLAUSE-IgAN Study: Iptacopan's Proteomic Signature in IgAN', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, TX, Houston, presented at Kidney Week, TX, Houston, 05 November 2025 - 09 November 2025
, 2025, 'Discordance Between Cystatin C-Based eGFR and Creatinine-Based eGFR and Cardiovascular Risk in the FLOW Trial', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, TX, Houston, presented at Kidney Week, TX, Houston, 05 November 2025 - 09 November 2025
, 2025, 'Effect of Semaglutide on Hemoglobin A1c and Body Weight Change by CKD Stage: Post Hoc Analysis from the FLOW Trial', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, TX, Houston, presented at Kidney Week, TX, Houston, 05 November 2025 - 09 November 2025
, 2025, 'Effect of Semaglutide on Kidney Outcomes: Pooled Analysis of the SELECT, FLOW, and SOUL Trials', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, TX, Houston, presented at Kidney Week, TX, Houston, 05 November 2025 - 09 November 2025
, 2025, 'Efficacy and Safety of Iptacopan in Patients (Pts) from East Asia with IgAN: Interim Results from the Phase 3 APPLAUSE-IgAN Trial', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, TX, Houston, presented at Kidney Week, TX, Houston, 05 November 2025 - 09 November 2025
, 2025, 'FLOW: Effects of Semaglutide on Kidney Failure Using the Kidney Failure Risk Equation', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, TX, Houston, presented at Kidney Week, TX, Houston, 05 November 2025 - 09 November 2025
, 2025, 'Glomerular Disease Registry and Biobank: Baseline and Follow-Up Results', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, TX, Houston, presented at Kidney Week, TX, Houston, 05 November 2025 - 09 November 2025
, 2025, 'Kidney, Cardiovascular, and Death Outcomes with Semaglutide Treatment Among Two Race and Two Ethnic Groups: Post Hoc Analysis from the FLOW Trial', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, TX, Houston, presented at Kidney Week, TX, Houston, 05 November 2025 - 09 November 2025